Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lalonde

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Journal of Submicroscopic Cytology|April 1, 1982
Ultrastructure and electron-probe x-ray analysis of the pigment in melanosis duodeniD J Pounder, F N Ghadially, T M Mukherjee, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|June 10, 2020
Sex chromosome aneuploidy alters the relationship between neuroanatomy and cognitionAllysa Warling, Siyuan Liu, Kathleen Wilson, et al.
Journal of Medicinal Chemistry|July 31, 2008
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenaseSanjeev Kumar, Daniel Jaller, Bhumika Patel, et al.
The Journal of Cell Biology|May 11, 2005
Regulation of phototransduction responsiveness and retinal degeneration by a phospholipase D-generated signaling lipidMary M LaLonde, Hilde Janssens, Erica Rosenbaum, et al.
Journal of Epidemiology and Community Health|December 20, 2002
Comparative analysis of nutrition data from national, household, and individual levels: results from a WHO-CINDI collaborative project in Canada, Finland, Poland, and SpainL Serra-Majem, D MacLean, L Ribas, et al.
Biochemistry|January 20, 1999
The crystal structure of human procathepsin KJ M LaLonde, B Zhao, C A Janson, et al.
Journal of Medicinal Chemistry|March 6, 2008
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitorsSanjeev Kumar, William P Malachowski, James B DuHadaway, et al.
Biochemistry|March 9, 2013
A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruptionAli Emileh, Ferit Tuzer, Herman Yeh, et al.
Biological Psychiatry|July 22, 2023
The Variegation of Human Brain Vulnerability to Rare Genetic Disorders and Convergence With Behaviorally Defined DisordersElizabeth Levitis, Siyuan Liu, Ethan T Whitman, et al.
Accounts of Chemical Research|February 8, 2014
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonistJoel R Courter, Navid Madani, Joseph Sodroski, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Journal of Submicroscopic Cytology|April 1, 1982
Ultrastructure and electron-probe x-ray analysis of the pigment in melanosis duodeniD J Pounder, F N Ghadially, T M Mukherjee, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|June 10, 2020
Sex chromosome aneuploidy alters the relationship between neuroanatomy and cognitionAllysa Warling, Siyuan Liu, Kathleen Wilson, et al.
Journal of Medicinal Chemistry|July 31, 2008
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenaseSanjeev Kumar, Daniel Jaller, Bhumika Patel, et al.
The Journal of Cell Biology|May 11, 2005
Regulation of phototransduction responsiveness and retinal degeneration by a phospholipase D-generated signaling lipidMary M LaLonde, Hilde Janssens, Erica Rosenbaum, et al.
Journal of Epidemiology and Community Health|December 20, 2002
Comparative analysis of nutrition data from national, household, and individual levels: results from a WHO-CINDI collaborative project in Canada, Finland, Poland, and SpainL Serra-Majem, D MacLean, L Ribas, et al.
Biochemistry|January 20, 1999
The crystal structure of human procathepsin KJ M LaLonde, B Zhao, C A Janson, et al.
Journal of Medicinal Chemistry|March 6, 2008
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitorsSanjeev Kumar, William P Malachowski, James B DuHadaway, et al.
Biochemistry|March 9, 2013
A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruptionAli Emileh, Ferit Tuzer, Herman Yeh, et al.
Biological Psychiatry|July 22, 2023
The Variegation of Human Brain Vulnerability to Rare Genetic Disorders and Convergence With Behaviorally Defined DisordersElizabeth Levitis, Siyuan Liu, Ethan T Whitman, et al.
Accounts of Chemical Research|February 8, 2014
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonistJoel R Courter, Navid Madani, Joseph Sodroski, et al.
Pageof 12